Published in Clin Orthop Relat Res on June 01, 1992
Locked patellar dislocation: a case report. J Med Case Rep (2008) 1.15
Locked lateral patellar dislocation with impaction fracture of patella. Ann R Coll Surg Engl (2002) 1.09
Irreducible lateral dislocation of patella with rotation. J Surg Case Rep (2012) 0.98
Neglected locked vertical patellar dislocation. Indian J Orthop (2012) 0.89
Patella dislocation with vertical axis rotation: the "dorsal fin" patella. Case Rep Orthop (2015) 0.82
Vertical Patellar Dislocation: Reduction by the Push Up and Rotate Method, A Case Report and Literature Review. Trauma Mon (2016) 0.75
Recurrent Patellar Instabilty Culminating in a Vertically Rotated and a Locked Patellar Dislocation - A Rare Entity. J Orthop Case Reports (2016) 0.75
Atraumatic Extra-articular Patellar Dislocation with Vertical Axis Rotation: A Case Study. J Orthop Case Reports (2016) 0.75
Irreducible Lateral Patellar Dislocation: A Case Report and Literature Review. Ochsner J (2016) 0.75
A Rare Case of an Irreducible Patella Dislocation. Case Rep Med (2016) 0.75
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86
Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet (1984) 3.54
Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ (2000) 2.92
Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer (2009) 2.79
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59
Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50
Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut (1991) 2.45
Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) 2.40
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst (2000) 2.24
Nitrates, nitrites and gastric cancer in Great Britain. Nature (1985) 2.15
Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer (2010) 2.13
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis (1997) 2.05
Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer (2008) 1.97
Helicobacter gastroduodenitis: a serious infectious disease. BMJ (1997) 1.90
Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology (1999) 1.83
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer (2007) 1.79
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Helicobacter pylori: a true carcinogen? Eur J Gastroenterol Hepatol (1998) 1.72
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol (2005) 1.63
H pylori and gastric cancer. Lancet (1994) 1.62
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev (2006) 1.61
Trends over time in Helicobacter pylori gastritis in Kenya. Eur J Gastroenterol Hepatol (2000) 1.59
Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer (1998) 1.56
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis (2003) 1.54
Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax (2006) 1.52
Lung cancer: district active treatment rates affect survival. J Epidemiol Community Health (2002) 1.51
Liver transplantation for acute hepatic failure? Lancet (1990) 1.50
CYP2D6 genotyping and the association with lung cancer susceptibility. Pharmacogenetics (1994) 1.50
Cancer information under threat: the case for legislation. Ann Oncol (2001) 1.49
Cancer of the liver and the use of oral contraceptives. Br Med J (Clin Res Ed) (1986) 1.49
Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer. Br J Cancer (2007) 1.48
Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev (2006) 1.47
Breast cancer outcomes in South Asian population of West Yorkshire. Br J Cancer (2004) 1.46
Surgeon workload and survival from breast cancer. Br J Cancer (2003) 1.45
Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. Br J Cancer (2011) 1.44
Delays in managing lung cancer. Thorax (2004) 1.37
Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer (2006) 1.33
Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut (2003) 1.32
Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. Br J Cancer (2004) 1.30
The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients. Br J Cancer (2006) 1.27
The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Aliment Pharmacol Ther (2002) 1.27
European health systems and cancer care. Ann Oncol (2003) 1.27
Initial management strategies for dyspepsia. Cochrane Database Syst Rev (2005) 1.26
Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer (2009) 1.26
Trends in mortality from carcinoma of the liver and the use of oral contraceptives. Br J Cancer (1983) 1.23
High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status? Br J Cancer (1996) 1.22
Initial management strategies for dyspepsia. Cochrane Database Syst Rev (2003) 1.22
The meaning of spirituality: a literature review. J Adv Nurs (1997) 1.21
Helicobacter pylori as a risk factor for cancer. Baillieres Clin Gastroenterol (1995) 1.19
Oral contraceptives and hepatocellular carcinoma. Br Med J (Clin Res Ed) (1986) 1.18
Mortality of nitrate fertiliser workers. Br J Ind Med (1986) 1.17
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol Assess (2007) 1.17
Travel times to health care and survival from cancers in Northern England. Eur J Cancer (2007) 1.16
Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group. Eur J Cancer (1998) 1.15
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma. Int J Cancer (1997) 1.15
An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer (1996) 1.11
The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol (2000) 1.11
Integrating cancer survivors' experiences into UK cancer registries: design and development of the ePOCS system (electronic Patient-reported Outcomes from Cancer Survivors). Br J Cancer (2011) 1.11
Postoperative wound complications and systemic recurrence in breast cancer. Br J Cancer (2007) 1.10
Declining mortality from breast cancer in Yorkshire, 1983-1998: extent and causes. Br J Cancer (2004) 1.10
Comparison of treatment and outcome information between a clinical trial and the National Cancer Data Repository. Br J Surg (2011) 1.09
Nitrate in drinking water and the incidence of gastric, esophageal, and brain cancer in Yorkshire, England. Cancer Causes Control (1998) 1.08
Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev (2005) 1.07
Risk factors for testicular germ cell tumours by histological tumour type. United Kingdom Testicular Cancer Study Group. Br J Cancer (1999) 1.06
Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol Biomarkers Prev (1993) 1.05
Exposure to vinyl chloride and angiosarcoma of the liver: a report of the register of cases. Br J Ind Med (1985) 1.04
Estimation of dietary intake of nitrate and nitrite in Great Britain. Food Chem Toxicol (1987) 1.04
Breast and cervical cancer in 187 countries between 1980 and 2010. Lancet (2012) 1.03
Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Cancer Causes Control (2001) 1.03
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev (2004) 1.03
TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort. Gut (2006) 1.03
Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006. Br J Cancer (2009) 1.01
Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomarkers Prev (1993) 1.00
Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst (1991) 0.99
An interaction between dorsal and ventral regions of the marginal zone in early amphibian embryos. J Embryol Exp Morphol (1980) 0.99
Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer (1996) 0.98
The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology (1994) 0.98
Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2000) 0.97
Declining incidence of gastric cancer. BMJ (1991) 0.97
A technique for arthroscopic subacromial decompression. Arthroscopy (1992) 0.97
Cancer of the cervix uteri and vitamin A. Br J Cancer (1986) 0.96
The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis (2010) 0.96
Candidate regions for a testicular cancer susceptibility gene. Hum Mol Genet (1995) 0.95
Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther (2006) 0.95
Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev (2003) 0.93
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev (2006) 0.93
Initial management strategies for dyspepsia. Cochrane Database Syst Rev (2001) 0.93
Pattern formation in Dictyostelium discoideum. II. Differentiation and pattern formation in non-polar aggregates. J Embryol Exp Morphol (1977) 0.92
The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology (2000) 0.92
The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's breast cancer patients. Ann Oncol (2007) 0.92